• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Drug Discovery | Pharma |News, Analysis, Insights - HIT Consultant

 

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery

by Fred Pennic 09/11/2024 Leave a Comment

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery

What You Should Know:  - Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.  - The startegic partnership leverages Genesis' cutting-edge AI platform, GEMS, to accelerate drug discovery and development. A Powerful Collaboration Genesis Therapeutics' GEMS platform utilizes advanced AI techniques to generate and
Read More

The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation

by Fred Pennic 08/21/2024 Leave a Comment

The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation

In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought to market. This transformation is not just limited to the research and development phases; AI is also playing a critical role in ensuring that drugs meet regulatory standards. The AI Revolution in Drug Discovery Drug discovery has traditionally been a
Read More

Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery

by Fred Pennic 08/14/2024 Leave a Comment

Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery

What You Should Know:  - Quantiphi, an AI-first digital engineering company, announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator. This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development. - By combining Quantiphi’s AI expertise with Transcell’s stem cell technology, the partnership aims to accelerate the development of innovative treatments while reducing
Read More

Absci and MSK Collaborate on Generative AI Drug Discovery

by Fred Pennic 08/12/2024 Leave a Comment

Absci and MSK Collaborate on Generative AI Drug Discovery

What You Should Know:  - Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics.  - By combining Absci’s AI platform with MSK’s renowned cancer research expertise, the partnership aims to accelerate the discovery and development of new treatments for this devastating disease. Absci's Integrated Drug Creation Platform Absci's Integrated
Read More

Genomics plc Expands Drug Discovery Collaboration with Vertex

by Syed Hamza Sohail 07/16/2024 Leave a Comment

Genomics plc Expands Drug Discovery Collaboration with Vertex

What You Should Know: -Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company’s collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to use human genetics and machine learning to improve the discovery and development of new precision medicines. -The partnership, which began in 2018, was previously extended in 2021. The collaboration will now run until 2026. Vertex and
Read More

Athos Therapeutics Taps Vultr Cloud GPU to Power AI Drug Discovery Engine

by Syed Hamza Sohail 06/19/2024 Leave a Comment

Athos Therapeutics Taps Vultr Cloud GPU to Power AI Drug Discovery Engine

What You Should Know: -              Vultr, the world’s largest, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. -              Powered by NVIDIA HGX H100 systems and running on Dell
Read More

Helix Launches Clinico-Genomic Datasets to Accelerate Precision Medicine Drug Discovery

by Fred Pennic 06/07/2024 Leave a Comment

Helix Launches Clinico-Genomic Datasets to Accelerate Precision Medicine Drug Discovery

What You Should Know:  - Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.  - These comprehensive datasets, built through collaborations with various health systems, provide researchers with a rich resource for drug discovery and development across multiple disease areas. Unveiling the Power of Clinico-Genomic Data The datasets offer a unique combination of longitudinal
Read More

Weave Bio Launches for AI-Powered Drug Development, Secures $10M

by Fred Pennic 05/30/2024 Leave a Comment

Weave Bio Launches for AI-Powered Drug Development, Secures $10M

What You Should Know:  - Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.  - AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications. Automating the IND Process: A Game-Changer for Drug
Read More

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

by Fred Pennic 05/21/2024 Leave a Comment

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

What You Should Know:  - Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration.  The first-of-its-kind partnership in the pharma and life sciences industries aims to leverage AI to accelerate drug development and bring new medicines to patients faster. - Sanofi, Formation Bio, and OpenAI believe this collaboration will be
Read More

Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery

by Fred Pennic 05/16/2024 Leave a Comment

Accenture Backs Turbine's AI-Powered Platform to Accelerate Drug Discovery

What You Should Know:  - Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.  - The investment aims to empower Turbine in extending its innovative technology to global biopharmaceutical companies seeking to unlock hidden biological insights and accelerate crucial drug development processes. Optimizing Drug Discovery with Simulated
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 13
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |